{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:09:09Z","timestamp":1791914949532,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The design of cereblon-binding molecular glues (MGs) that selectively recruit a desired protein while excluding teratogenic SALL4 is an area of significant interest when designing therapeutic agents. Previous studies show that SALL4 is degraded in the presence of IKZF1 degraders pomalidomide, and to a lesser extent by CC-220. To expand our understanding of the molecular basis for the interaction of SALL4 with cereblon, we performed biophysical and structural studies demonstrating that SALL4 zinc finger domains one and two (ZF1-2) interact with cereblon (CRBN) in a unique manner. ZF1 interacts with the\n                    <jats:italic>N-<\/jats:italic>\n                    terminal domain of cereblon and ZF2 binds as expected in the\n                    <jats:italic>C-<\/jats:italic>\n                    terminal IMiD-binding domain. Both ZF1 and ZF2 contribute to the potency of the interaction of ZF1-2 with CRBN:MG complexes and the affinities of SALL4 ZF1-2 for the cereblon:CC-220 complex are less potent than for the corresponding pomalidomide complex. Structural analysis provides a rationale for understanding the reduced affinity of SALL4 for cereblon in the presence of CC-220, which engages both ZF1 and ZF2. These studies further our understanding of the molecular glue-mediated interactions of zinc finger-based proteins with cereblon and may provide structural tools for the prospective design of compounds with reduced binding and degradation of SALL4.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-48606-3","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T18:04:11Z","timestamp":1702404251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiaolei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Dovala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tandeske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwynn","family":"Pardee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephania","family":"Widger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan E. J.","family":"Beckwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Wartchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"issue":"10","key":"48606_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","volume":"15","author":"PP Chamberlain","year":"2019","unstructured":"Chamberlain, P. P. & Hamann, L. G. Development of targeted protein degradation therapeutics. Nat. Chem. Biol. 15(10), 937\u2013944. https:\/\/doi.org\/10.1038\/s41589-019-0362-y (2019).","journal-title":"Nat. Chem. Biol."},{"key":"48606_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ddtec.2019.02.004","volume":"31","author":"PP Chamberlain","year":"2019","unstructured":"Chamberlain, P. P. & Cathers, B. E. Cereblon modulators: Low molecular weight inducers of protein degradation. Drug Discov. Today Technol. 31, 29\u201334. https:\/\/doi.org\/10.1016\/j.ddtec.2019.02.004 (2019).","journal-title":"Drug Discov. Today Technol."},{"key":"48606_CR3","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1126\/science.aat0572","volume":"362","author":"QL Sievers","year":"2018","unstructured":"Sievers, Q. L. et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 362, 6414. https:\/\/doi.org\/10.1126\/science.aat0572 (2018).","journal-title":"Science"},{"key":"48606_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature16979","volume":"532","author":"G Petzold","year":"2016","unstructured":"Petzold, G., Fischer, E. & Thom\u00e4, N. Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4CRBN ubiquitin ligase. Nature 532, 127\u2013130. https:\/\/doi.org\/10.1038\/nature16979 (2016).","journal-title":"Nature"},{"issue":"2","key":"48606_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1021\/acs.jmedchem.6b01921","volume":"61","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela, M. E. et al. A cereblon modulator (CC-220) with improved degradation of Ikaros and Aiolos. J. Med. Chem. 61(2), 535\u2013542. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01921 (2018).","journal-title":"J. Med. Chem."},{"key":"48606_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38430","volume":"7","author":"KA Donovan","year":"2018","unstructured":"Donovan, K. A. et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome. Elife 7, e38430. https:\/\/doi.org\/10.7554\/eLife.38430 (2018).","journal-title":"Elife"},{"issue":"6619","key":"48606_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1126\/science.add7574","volume":"378","author":"ER Watson","year":"2022","unstructured":"Watson, E. R. et al. Molecular glue CELMoD compounds are regulators of cereblon conformation. Science 378(6619), 549\u2013553. https:\/\/doi.org\/10.1126\/science.add7574 (2022).","journal-title":"Science"},{"issue":"4","key":"48606_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41594-020-0405-9","volume":"27","author":"ME Matyskiela","year":"2020","unstructured":"Matyskiela, M. E. et al. Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex. Nat. Struct. Mol. Biol. 27(4), 319\u2013322. https:\/\/doi.org\/10.1038\/s41594-020-0405-9 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6","key":"48606_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41589-021-00802-w","volume":"17","author":"ES Wang","year":"2021","unstructured":"Wang, E. S. et al. Acute pharmacological degradation of Helios destabilizes regulatory T cells. Nat. Chem. Biol. 17(6), 711\u2013717. https:\/\/doi.org\/10.1038\/s41589-021-00802-w (2021).","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"48606_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.chembiol.2023.02.005","volume":"30","author":"S Bonazzi","year":"2023","unstructured":"Bonazzi, S. et al. Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy. Cell Chem. Biol. 30(3), 235\u2013247. https:\/\/doi.org\/10.1016\/j.chembiol.2023.02.005 (2023).","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"48606_CR11","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1038\/s41467-020-18488-4","volume":"11","author":"H Furihata","year":"2020","unstructured":"Furihata, H. et al. Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide. Nat. Commun. 11(1), 4578. https:\/\/doi.org\/10.1038\/s41467-020-18488-4 (2020).","journal-title":"Nat. Commun."},{"issue":"10","key":"48606_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","volume":"14","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela, M. E. et al. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Nat. Chem. Biol. 14(10), 981\u2013987. https:\/\/doi.org\/10.1038\/s41589-018-0129-x (2018).","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"48606_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s42003-020-01240-5","volume":"3","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka, S. et al. An IMiD-induced SALL4 degron system for selective degradation of target proteins. Commun. Biol. 3(1), 515. https:\/\/doi.org\/10.1038\/s42003-020-01240-5 (2020).","journal-title":"Commun. Biol."},{"issue":"21","key":"48606_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bbrc.2008.08.149","volume":"3","author":"I Satoshi","year":"2008","unstructured":"Satoshi, I. & Yuiko, S. Soluble protein expression in E. coli Cells using IgG-binding domain of protein A as a solubilizing partner in the cold induced system. Biochem. Biophys. Res. Commun. 3(21), 448\u2013453. https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.149 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"48606_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2272-7_12","volume-title":"Site-Specific Protein Labeling. Methods in Molecular Biology","author":"M Fairhead","year":"2015","unstructured":"Fairhead, M. & Howarth, M. Site-specific biotinylation of purified proteins using BirA. In Site-Specific Protein Labeling. Methods in Molecular Biology Vol. 1266 (eds Gautier, A. & Hinner, M.) (Humana Press, 2015). https:\/\/doi.org\/10.1007\/978-1-4939-2272-7_12."},{"issue":"1","key":"48606_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pep.2013.08.021","volume":"92","author":"T Schmidt","year":"2013","unstructured":"Schmidt, T. et al. Development of the twin-strep-tag and its application for purification of recombinant proteins from cell culture supernatants. Protein Expr. Purif. 92(1), 54\u201361. https:\/\/doi.org\/10.1016\/j.pep.2013.08.021 (2013).","journal-title":"Protein Expr. Purif."},{"key":"48606_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"A McCoy","year":"2007","unstructured":"McCoy, A. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674. https:\/\/doi.org\/10.1107\/S0021889807021206 (2007).","journal-title":"J. Appl. Crystallogr."},{"issue":"7","key":"48606_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1107\/S0907444903008126","volume":"59","author":"E Potterton","year":"2003","unstructured":"Potterton, E., Briggs, P., Turkenburg, M. & Dodson, E. A graphical user interface to the CCP4 program suite. Acta Crystallogr. D Biol. Crystallogr. 59(7), 1131\u20131137. https:\/\/doi.org\/10.1107\/S0907444903008126 (2003).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"48606_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P. et al. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501. https:\/\/doi.org\/10.1107\/S0907444910007493 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"48606_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"P Afonine","year":"2012","unstructured":"Afonine, P. et al. Towards automated crystallographic structure refinement with phenix. refine. Acta Cryst. D Biol. Crystallogr. 68, 352\u2013367. https:\/\/doi.org\/10.1107\/S0907444912001308 (2012).","journal-title":"Acta Cryst. D Biol. Crystallogr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48606-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T18:04:24Z","timestamp":1702404264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48606-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48606"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48606-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3349351\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"12 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Many authors are Novartis shareholders.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22088"}}